DATATRAK inks multi-year agreement with specialty biotech company
DATATRAK International, a technology and services company focused on global eClinical solutions for the clinical trials industry, has signed a multi-year enterprise agreement with a specialty biologics and vaccines company. Recognizing the value of enterprise engagements, the specialty biotech will utilize the DATATRAK ONE unified software suite to conduct a series of trials.
"We are pleased to add a new biotech company to our Connect Partner Program and Product Advisory Council. Their input into the growth of our products will be invaluable," stated Laurence P. Birch, DATATRAK's chairman of the board and CEO. "Signing another Enterprise client demonstrates the commitment to DATATRAK's unified product suite and exemplifies the industry's need for a single solution to conducting clinical trials from Concept to Cure."